HepaLife(TM) Acquires Liver Support Technology, Tested in America's Largest-Ever Human Clinical Trial for Bioartificial Liver Assist Devices
HepaLife(TM) Announces Expansion of Exclusive License Agreement with U.S. Government Agency for Liver Cell Line
HepaLife(TM) Develops New Liver Stem Cell Lines for Bioartificial Liver Device; Data Presented at Scientific Conferences
HepaLife(TM) Completes $4.5 Million Private Placement
HepaLife's Bioartificial Liver Exceeds Expectations in New Tests Conducted over Prolonged Periods of Time
New Artificial Liver Tests: HepaLife's 'PICM-19' Demonstrate Advantages Over Today's Best-Available Liver Cells
HepaLife(TM) to Present Bioartificial Liver Device Data at International Stem Cell Conference
HepaLife's Bioartificial Liver Successful in Important Studies Modeling Human Liver Failure Environment
HepaLife(TM) to Present New Bioartificial Liver Device Data at Major National Scientific Conference
